Back to search

Article

Optical genome mapping identifies a novel <i>PSIP1::TBL1X</i> fusion in metastatic pancreatic neuroendocrine tumors

2025-12-19

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background and aims</h4> Effective treatment of metastatic neuroendocrine tumors (NETs) is limited by a lack of targeted therapies and clinically useful predictive biomarkers. We applied complementary genomic profiling technologies to identify genomic alterations that could lead to actionable drug targets and biomarkers. <h4>Methods</h4> Optical genome mapping (OGM) and whole exome sequenc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
011c85e8-f8f9-50a5-9b95-dbee2ed50f19
DOI
10.64898/2025.12.17.694687
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Optical genome mapping identifies a novel <i>PSIP1::TBL1X</i> fusion in metastatic pancreatic neuroendocrine tumorsDOI 10.64898/2025.12.17.694687
Select a neighboring publication to make it the new centre.